Stocktoria
CASTLE BIOSCIENCES INC CSTL
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2019-07-25
CASTLE BIOSCIENCES INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $344.2M | $332.1M | $219.8M | $137.0M | $94.1M |
| R&D expense | $51.9M | $52.0M | $53.6M | $44.9M | $29.6M |
| SG&A expense | $229.3M | $200.0M | $180.2M | $143.0M | $86.7M |
| Operating income | -$42.8M | $8.7M | -$68.0M | -$72.9M | -$40.1M |
| Interest expense | — | — | $11,000 | $17,000 | $1,000 |
| Income tax | -$5.4M | $3.3M | $101,000 | -$1.8M | -$8.7M |
| Net income | -$24.2M | $18.2M | -$57.5M | -$67.1M | -$31.3M |
| EPS (diluted) | $-0.83 | $0.62 | $-2.14 | $-2.58 | $-1.24 |
| Operating cash flow | $64.3M | $64.9M | -$5.6M | -$41.7M | -$19.0M |
| Free cash flow | $28.3M | $36.5M | -$19.2M | -$47.3M | -$22.5M |
| Cash & equivalents | $116.7M | $119.7M | $98.8M | $122.9M | $329.6M |
| Inventory | $10.3M | $8.1M | $7.9M | $4.0M | $2.0M |
| Total assets | $578.6M | $531.2M | $453.3M | $447.3M | $462.6M |
| Total liabilities | $107.7M | $75.4M | $62.1M | $48.2M | $50.8M |
| Shareholders' equity | $470.9M | $455.8M | $391.3M | $399.1M | $411.7M |
Source: SEC EDGAR filings · CIK 0001447362 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.